Publications by authors named "Eliza Miller"

Background: Individuals with adverse pregnancy outcomes have an increased risk of cerebrovascular disease, but the association between adverse pregnancy outcomes and cognitive impairment and dementia is less well established. We aimed to synthesise, combine, and assess the growing body of data examining the associations between adverse pregnancy outcomes and mild cognitive impairment and dementia in parous women.

Methods: In this systematic review and meta-analysis, we searched PubMed (MEDLINE), Web of Science, and Embase from database inception up to July 18, 2024, with no language restrictions, for observational studies or clinical trials that reported mild cognitive impairment or dementia as outcomes and included female individuals or women who had an adverse pregnancy outcome, including hypertensive disorders of pregnancy, gestational diabetes, stillbirth, fetal growth restriction, preterm birth, or placental abruption.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the effects of continuing osimertinib alongside platinum-pemetrexed chemotherapy for patients with EGFR mutant non-small cell lung cancer (NSCLC) who have had disease progression on osimertinib.
  • It analyzed data from 159 eligible patients out of 421 identified, comparing outcomes between two groups: one continuing osimertinib with chemotherapy and the other receiving chemotherapy alone.
  • Results showed that the group continuing osimertinib experienced a significant improvement in progression-free survival (9.0 months vs. 4.5 months), indicating a potential clinical benefit in this treatment strategy.
View Article and Find Full Text PDF

Objective:  In this study, we piloted the use of continuous 24-hour blood pressure (BP) monitoring in postpartum patients with preeclampsia with severe features.

Study Design:  We measured continuous BP for up to 24 hours using finger plethysmography. We also used an oscillometric device to measure brachial BP per usual clinical protocol (intermittent BP) during the same monitoring period.

View Article and Find Full Text PDF

Objective:  This study aimed to compare the effectiveness of oral short-acting (SA) nifedipine with intravenous (IV) labetalol for the treatment of postpartum (PP) severe hypertension.

Study Design:  We conducted a retrospective cohort study of women who delivered at a tertiary care facility between January and December 2018, had not previously received antihypertensive medication, and required treatment for PP severe hypertension defined as systolic blood pressure (SBP) ≥ 160 mm Hg and/or diastolic blood pressure (DBP) ≥110 mm Hg. Exposure groups were defined by the receipt of either oral SA nifedipine or IV labetalol.

View Article and Find Full Text PDF
Article Synopsis
  • The "2024 Guideline for the Primary Prevention of Stroke" updates the previous 2014 guidelines, providing new strategies for preventing strokes in individuals without a prior history.
  • A thorough review of relevant literature from various databases was conducted to inform these updated recommendations, ensuring they are based on the latest research.
  • The guidelines emphasize the preventability of strokes and include new sex-specific recommendations, aligning with the American Heart Association's Life's Essential 8, while also updating previous recommendations based on recent research findings.
View Article and Find Full Text PDF

Background: Case reports describe arterial thrombosis including ischemic stroke associated with severe ovarian hyperstimulation syndrome (OHSS), but the prevalence of major ischemic events during or shortly after OHSS is unknown.

Methods: Using publicly available administrative datasets in the United States between 2015 and 2020, we conducted two separate cross-sectional studies of patients with OHSS. We included all patients with OHSS.

View Article and Find Full Text PDF

Importance: Hypertension is increasingly common in pregnancy capable individuals, yet there is limited data on antihypertensive medication dispensation in peripartum individuals.

Objective: To describe antihypertensive medication dispensation from preconception through the first year postpartum.

Design, Setting, And Participants: This retrospective cohort study used the Truven Health Market Scan administrative data from 2008 to 2014 to identify women in the United States with commercial or government health insurance, aged 15-54, free from heart disease, who experienced a pregnancy and filled at least 1 prescription for an antihypertensive medication between 3 months prior to conception and 12 months after the end of the pregnancy.

View Article and Find Full Text PDF

Background: Peripartum cardiomyopathy (PPCM), a form of heart failure with reduced ejection fraction (HFrEF) that occurs during the final month of pregnancy through the first 5 months postpartum, is associated with heightened risk for maternal morbidity and mortality. Stroke is a common complication of HFrEF but there is limited data on the incidence of stroke in PPCM.

Methods: Using statewide, nonfederal administrative data from 2000 to 2015, we analyzed age-adjusted risk of stroke within 3 years after PPCM-associated pregnancies.

View Article and Find Full Text PDF
Article Synopsis
  • Intracerebral hemorrhage (ICH) poses significant risks during and after pregnancy, with a study examining its characteristics in pregnant individuals compared to nonpregnant adults.
  • Among 134 young adults analyzed, 19% experienced pregnancy-associated ICH (P-ICH), primarily occurring in the postpartum period, and P-ICH showed a higher likelihood of being primary (spontaneous) compared to nonpregnant women.
  • Despite lower in-hospital mortality rates for P-ICH patients (4%) versus nonpregnant women (13%) and men (24%), a quarter of P-ICH patients were left bedbound or dependent upon discharge, indicating serious functional impairments.
View Article and Find Full Text PDF

A State of the Art lecture titled "Impact of Adverse Pregnancy Outcomes on Brain Vascular Health and Cognition" was presented at the International Society on Thrombosis and Haemostasis Congress in 2023. Adverse pregnancy outcomes, encompassing conditions such as gestational hypertension, eclampsia, preeclampsia, preterm birth, fetal growth restriction, stillbirth, and gestational diabetes, may form part of an underrecognized pathway from early adulthood reproductive health factors to later-life vascular cognitive impairment and dementia in women. Adverse pregnancy outcomes are caused by dysregulated vascular and metabolic adaptations during pregnancy, and these pathophysiological changes may persist after delivery.

View Article and Find Full Text PDF
Article Synopsis
  • * The scientific statement reviews preventive strategies using the American Heart Association's Life's Essential 8 framework, focusing on blood pressure management and lifestyle changes for better cardiovascular health.
  • * There is a need for future trials to improve screening and interventions during the fourth trimester (the 12 weeks after delivery) to enhance cardiovascular health in those affected by adverse pregnancy outcomes.
View Article and Find Full Text PDF

Background: Exposure to radon has been linked to lung cancer and other lung diseases. Although biologically plausible, research of residential radon exposure in relation to stroke risk is scarce.

Methods: Study participants were from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) cohort (n=30 239), which consisted of male and female non-Hispanic Black and White adults aged 45 and older.

View Article and Find Full Text PDF
Article Synopsis
  • Obesity is linked to both negative pregnancy outcomes and an increased risk of heart disease, but it's unclear if these pregnancy outcomes are a cause or a result of the obesity-heart disease connection.
  • This study involved nearly 4,216 first-time pregnant women monitored over time to explore how early pregnancy body mass index (BMI) influenced cardiovascular risk factors after childbirth, considering various pregnancy complications.
  • Results indicated that early pregnancy obesity was associated with higher rates of conditions like postpartum hypertension, high cholesterol, and diabetes, with pregnancy-related complications also contributing to these risks, particularly hypertensive disorders.
View Article and Find Full Text PDF

Reproductive factors, including parity, may contribute to dementia risk, due to hormonal, physiological, social, and demographic factors. We hypothesized that higher parity would be associated with increased dementia risk. We utilized data from the Atherosclerosis Risk in Communities (ARIC) community-based cohort study.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how changes in dynamic cerebral autoregulation (DCA) affect mothers after experiencing severe preeclampsia postpartum, compared to healthy postpartum and non-pregnant women.
  • Researchers used techniques like transcranial Doppler and blood pressure monitoring to measure DCA parameters within a week of delivery in these groups.
  • Results indicated that postpartum participants showed faster autoregulatory responses but with impaired dampening effects, suggesting a hyperdynamic state in DCA regardless of preeclampsia status.
View Article and Find Full Text PDF

Background: Adverse pregnancy outcomes (APO) contribute to higher risk of maternal cerebrovascular disease, but longitudinal data that include APO and stroke timing are lacking. We hypothesized that APO are associated with younger age at first stroke, with a stronger relationship in those with >1 pregnancy with APO.

Methods: We analyzed longitudinal Finnish nationwide health registry data from the FinnGen Study.

View Article and Find Full Text PDF

Background: Critically ill patients with obesity have unique and complex nutritional needs, with clinical practice guidelines conflicting regarding recommended energy targets. The aim of this systematic review was to 1) describe measured resting energy expenditure (mREE) reported in the literature and; 2) compare mREE to predicted energy targets using the European (ESPEN) and American (ASPEN) guideline recommendations when indirect calorimetry is not available in critically ill patients with obesity.

Methods: The protocol was registered apriori and literature was searched until 17th March, 2022.

View Article and Find Full Text PDF
Article Synopsis
  • * It notes that disparities in cardiovascular health exist among different racial, ethnic, and socioeconomic groups, impacting access to care and health outcomes.
  • * The authors advocate for interventions that start early in life and at the community and policy levels to improve cardiovascular health and reduce structural inequalities in healthcare access for reproductive-aged individuals.
View Article and Find Full Text PDF

Importance: The Mediterranean diet pattern is inversely associated with the leading causes of morbidity and mortality, including metabolic diseases and cardiovascular disease, but there are limited data on its association with adverse pregnancy outcomes (APOs) among US women.

Objective: To evaluate whether concordance to a Mediterranean diet pattern around the time of conception is associated with lower risk of developing any APO and individual APOs.

Design, Setting, And Participants: This prospective, multicenter, cohort study, the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be, enrolled 10 038 women between October 1, 2010, and September 30, 2013, with a final analytic sample of 7798 racially, ethnically, and geographically diverse women with singleton pregnancies who had complete diet data.

View Article and Find Full Text PDF

Background Impaired coronary endothelial function (CEF) predicts cardiovascular events and occurs in people living with HIV (PLWH). Women compared with men living with HIV have worse cardiovascular outcomes, but prior CEF studies included few women. The authors aimed to compare CEF in women with HIV versus without HIV, investigate sex differences in CEF and PCSK9 (proprotein convertase subtilisin/kexin type 9) (a proinflammatory biomarker), and evaluate whether increased serum levels of PCSK9 are associated with CEF in PLWH.

View Article and Find Full Text PDF